loader
Please Wait
Applying Filters...

Minakem Generic APIs Minakem Generic APIs

X

Technical details about Mirdametinib, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 391210-10-9, Pd0325901, Pd 0325901, Pd-0325901, Mirdametinib, (r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide
Molecular Formula
C16H14F3IN2O4
Molecular Weight
482.19  g/mol
InChI Key
SUDAHWBOROXANE-SECBINFHSA-N
FDA UNII
86K0J5AK6M

Mirdametinib is an orally bioavailable, synthetic organic molecule targeting mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. Upon administration, mirdametinib selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation. The dual specific threonine/tyrosine kinase MEK is a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide
2.1.2 InChI
InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1
2.1.3 InChI Key
SUDAHWBOROXANE-SECBINFHSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O
2.1.5 Isomeric SMILES
C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O
2.2 Other Identifiers
2.2.1 UNII
86K0J5AK6M
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Mirdametinib

2. Pd 0325901

3. Pd 325901

4. Pd-0325901

5. Pd-325901

6. Pd0325901

7. Pd325901

2.3.2 Depositor-Supplied Synonyms

1. 391210-10-9

2. Pd0325901

3. Pd 0325901

4. Pd-0325901

5. Mirdametinib

6. (r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide

7. Pd-325901

8. (r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide

9. Pd 325901

10. Mirdametinib [usan]

11. Pd325901

12. 86k0j5ak6m

13. Chembl507361

14. Chebi:88249

15. Pd 901

16. N-{[(2r)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

17. Mirdametinib (usan)

18. Ncgc00189075-01

19. Pd 03525901

20. N-((r)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide

21. N-[((r)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

22. N-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide

23. 391209-97-5

24. Unii-86k0j5ak6m

25. N-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide

26. 4bm

27. N-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide

28. N-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-benzamide

29. Mirdametinib [inn]

30. Dsstox_cid_24024

31. Dsstox_rid_80100

32. Dsstox_gsid_44024

33. Mirdametinib [who-dd]

34. Pd0325901(mirdametinib)

35. Schembl172904

36. Gtpl7935

37. Dtxsid0044024

38. Ex-a102

39. Bcpp000126

40. Bdbm104963

41. Hms3648a14

42. Amy36437

43. Zinc3938683

44. Tox21_113364

45. Mfcd09909925

46. Nsc755770

47. Nsc800840

48. S1036

49. Who 11299

50. Akos015855518

51. Bcp9001057

52. Ccg-221316

53. Cs-0062

54. Db07101

55. Ex-8602

56. Nsc-755770

57. Nsc-800840

58. Ncgc00381744-09

59. Hy-10254

60. Us8575391, Q

61. Bb 0261791

62. Cas-391210-10-9

63. Sw218101-2

64. D11675

65. Pd-0325901,pd325901

66. Pd 0325901, >=98% (hplc)

67. Pd0325901 (pd325901)

68. Sr-01000946344

69. J-502503

70. Sr-01000946344-1

71. Brd-k49865102-001-01-9

72. Q27088255

73. Insolution Mek1/2 Inhibitor Iii, Pd0325901 - Cas 391210-10-9

74. Benzamide,n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-

75. N-((r)-2,3-dihydroxy[propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide

76. N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide

77. N-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- Benzamide

78. N-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2[(2-fluoro-4-iodophenyl)amino]-benzamide

79. (-)-n-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide

80. N-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide N-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 482.19 g/mol
Molecular Formula C16H14F3IN2O4
XLogP33
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count8
Rotatable Bond Count7
Exact Mass481.99504 g/mol
Monoisotopic Mass481.99504 g/mol
Topological Polar Surface Area90.8 Ų
Heavy Atom Count26
Formal Charge0
Complexity465
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY